Cancer of unknown primary inside the gastric wall identified by endoscopic submucosal dissection.


Journal

Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 07 10 2020
accepted: 04 11 2020
pubmed: 19 11 2020
medline: 29 6 2021
entrez: 18 11 2020
Statut: ppublish

Résumé

We report the rare and interesting case of cancer of unknown primary (CUP) detected by endoscopic submucosal dissection (ESD). A 67-year-old man with a gastric adenoma was referred to our hospital for endoscopic treatment. Esophagogastroduodenoscopy revealed a 15-mm submucosal tumor (SMT) at the lesser curvature of the lower gastric body, near the gastric adenoma. Both lesions were resected by ESD. Pathological examination showed that the SMT was a poorly differentiated adenocarcinoma with lymphatic tissue. Additional surgical resection was performed, and the lymph nodes were found to have the same pathological findings as the SMT. These lesions were diagnosed as CUP because the obvious primary site was not detected with additional examination. The patient has been followed up for 24 months without recurrence.

Identifiants

pubmed: 33206368
doi: 10.1007/s12328-020-01297-z
pii: 10.1007/s12328-020-01297-z
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

506-510

Références

Holmes FF, Fouts TL. Metastatic cancer of unknown primary site. Cancer. 1970;26:816–20.
doi: 10.1002/1097-0142(197010)26:4<816::AID-CNCR2820260413>3.0.CO;2-R
Pavlidis N, Briasoulis E, Hainsworth J, et al. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39:1990–2005.
doi: 10.1016/S0959-8049(03)00547-1
Fizazi K, Greco FA, Pavlidis N, et al. Cancers of unknown primary site: ESMO Clinical Practice Guide lines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22(Suppl 6):vi64–8.
doi: 10.1093/annonc/mdr389
Brustugun OT, Helland A. Rapid reduction in the incidence of cancer of unknown primary. A population-based study. Acta Oncol. 2014;53:134–7.
doi: 10.3109/0284186X.2013.783230
Urban D, Rao A, Bressel M, et al. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Br J Cancer. 2013;109:1318–24.
doi: 10.1038/bjc.2013.386
Lenzi R, Hess KR, Abbruzzese MC, et al. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown primary carcinoma? J Clin Oncol. 1997;15:2056–66.
doi: 10.1200/JCO.1997.15.5.2056
Chorost MI, Lee MC, Yeoh CCB, et al. Unknown primary. J Surg Oncol. 2004;87:191–203.
doi: 10.1002/jso.20099
Carneiro F, Fukayama M, Grabsch HI, et al. Gastric adenocarcinoma. WHO Classification of Tumours 5th edition. Digestive System Tumours 2019; 85–95.
Imamura T, Konishi H, Ichikawa D, et al. Gastric carcinoma originating from the heterotopic submucosal gastric gland treated by laparoscopy cooperative surgery. World J Gastrointest Oncol. 2015;15:118–22.
doi: 10.4251/wjgo.v7.i8.118
Kim DH, Kim KM, Oh SJ, et al. Early gastric cancer arising from heterotopic gastric mucosa in the gastric submucosa. J Korean Surg Soc. 2011;80(Suppl 1):S6–11.
doi: 10.4174/jkss.2011.80.Suppl1.S6
Nishimaki T, Suzuki T, Tanaka Y, et al. Intramural metastates from thoracic esophageal cancer: local indicators of advanced disease. World J Surg. 1996;20:32–7.
doi: 10.1007/s002689900006
Hashimoto T, Arai K, Yamashita Y, et al. Characteristics of intramural metastasis in gastric cancer. Gastr Cancer. 2013;16:537–42.
doi: 10.1007/s10120-012-0228-4
Okuno N, Hara K, Tajika M, et al. Gastrointestinal submucosal tumor diagnosis-EUS and EUS-FNA. Stomach Intestine. 2018;53:1756–67 (in Japanese with English abstract).

Auteurs

Ippei Tanaka (I)

Department of Gastroenterology, Sendai Kousei Hospital, 4-15, Hirose-machi, Aoba-ku, Sendai, Miyagi, 980-0873, Japan. ippeitanaka777@gmail.com.

Dai Hirasawa (D)

Department of Gastroenterology, Sendai Kousei Hospital, 4-15, Hirose-machi, Aoba-ku, Sendai, Miyagi, 980-0873, Japan.

Hiroaki Saito (H)

Department of Gastroenterology, Sendai Kousei Hospital, 4-15, Hirose-machi, Aoba-ku, Sendai, Miyagi, 980-0873, Japan.

Junichi Akahira (J)

Department of Pathology, Sendai Kousei Hospital, 4-15, Hirose-machi, Aoba-ku, Sendai, Miyagi, 980-0873, Japan.

Tomoki Matsuda (T)

Department of Gastroenterology, Sendai Kousei Hospital, 4-15, Hirose-machi, Aoba-ku, Sendai, Miyagi, 980-0873, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH